Navigation Links
Changes In Brain Structure From Methamphetamine Abuse And HIV Infection

The research reported in the latest issue of American Journal of Psychiatry had said that both Methamphetamine Abuse and HIV Infection can cause significant changes in the brain structures that can later affect the cognitive // functions like learning new things, problem solving, paying attention to something and processing information. The results are more if both the conditions happen simultaneously.

Methamphetamine abuse is linked with HIV, hepatitis C, and other sexually transmitted diseases, not only by the use of contaminated injection equipment, but also due to increased risky sexual behaviors. These findings show that methamphetamine abuse and HIV infection each cause significant changes in the volume of brain gray matter structures and cognitive function.

Scientists from University of California-San Diego had conducted brain scans to analyze structural volume changes in 103 adults divided among four populations: methamphetamine abusers who were HIV-positive; methamphetamine abusers who were HIV-negative; non-abusers who were HIV-positive; and non-abusers who were HIV-negative. They also assessed the ability to think and reason using a detailed battery of tests that examined speed of information processing, attention/working memory, learning and delayed recall, abstraction/executive functioning, verbal fluency, and motor functioning.

They observed that methamphetamine abuse is associated with increases in the volume of the brain’s parietal cortex (which helps people to understand and pay attention to what’s going on around them) and basal ganglia (linked to motor function and motivation). HIV infection is associated with prominent volume losses in the cerebral cortex (involved in higher thought, reasoning, and memory), basal ganglia, and hippocampus (involved in memory and learning).

In methamphetamine abusers who are also HIV-positive, decreased volumes are correlated with increased cognitive impairment in one b
'"/>




Page: 1 2

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. Changes in cabin pressure pose risks for moms-to-be
3. Dietary Changes Could Reduce The Risk for Stroke
4. Link Between High Blood Sugar And Behavioral Changes
5. Specific Changes In A Particular Gene Found To Increase The Risk of Alzheimer’s Diseas
6. Ultrasounds To Detect Changes In Heart Motions
7. Age Can Changes Symptoms Of Sinusitis
8. New Research To Study Brain Changes In Premature Births
9. MRI Shows Emotional Changes During Menstrual Cycle
10. Psychosocial Disability Varies In Accordance With Bipolar Symptom Changes
11. DNA Underwent Changes Due To Culture
Post Your Comments:
(Date:1/8/2009)...an. 8 Cephalon, Inc . (...o, Jr., Ph.D., Chairman and CEO will present at t...n January 13, 2009 in San Francisco, CA at approxi...). The presentation will be webcast live on the in... , , The webcast will be archived for one week...
(Date:1/8/2009)...l Encryption business continues to drive overall p...Call/ -- Zix Corporation (ZixCorp(R)), (Nasdaq: ...cryption and e-prescribing, today offered a corpor...urr. , , "We ended the year on a high note in o...hest orders for the year in the fourth quarter," s...
(Date:1/8/2009)...ly-navigated guidewire provides minimally-invasive...STIN, Texas, Jan. 8 The Heart Hos...d to use the new Stereotaxis RF PowerAssert(TM) Ma...al occlusions (CTOs), or complete blockages in pat...n Heart interventional cardiologist, Frank Zidar, ...
(Date:1/8/2009)...enn., Jan. 8 St. Jude Children,s R...announced that FedExCup Runner-Up,Camilo Villegas...de with a,pledge to match Singh,s donation of $5,...009 PGA TOUR. Eagles for St. Jude is a powerful p...n Vijay Singh and rising LPGA star Morgan,Pressel...
Breaking Medicine News(10 mins):Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 4Health News:Heart Hospital of Austin First in World to Use New Device for Blocked Arteries 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4
...who are enrolled for early health check up program...develop to be healthier adults than those who do n...the children who had participated early in these h...cently published its findings. Researchers of Chil...
... study shows that anti-smoking advertisements in m...ers. // Researcher Sherry Emery examined the assoc...rtising and youth smoking-related beliefs and beha...l-based samples of 51,085 students from 48 states....
...y ‘Noise’ is not always a bad thing!! Researchers ... that // noise can at times help, rather than hind...nusual to have an aversion for noise unless you ar... noise in India during Diwali can be deafening and...
...reenberg and colleagues compared their Cell cultur...ture with calf lymph derived vaccine. Small pox va... virus derived from calf lymph. This vaccine produ...serious or life threatening adverse reactions of e...
Other Medicine News:Health News:‘Loud Noise’ Research may help in Development of Prosthetics for Elder 2
(Date:1/6/2009)...In recent controlled studies conducted by Dr. Rich...ound that the patented ingredient in Glyc,n Go(TM)...dient to increase levels of nitric oxide (NO) in t...(NOx) in human subjects. , , Nitric oxide acts ...flow to the skeletal muscles. This is significant...
(Date:1/6/2009)...re-FirstCall/ -- , - Early Renewal of the A...er 2011 , - Expansion of the Scope of the C...thalmology , - Revised Commercial Terms and... Third Party , ExonHit Therapeutics (Alte...its existing drug discovery collaboration with All...
(Date:12/30/2008)...wire/ -- The Coalition for 21st Century Medicine s...ntech, Inc. on December 5, 2008, seeking to restri... tests to physicians and patients. The request th... patient care and rests on flawed scientific and l...o encourage the research, development, and commerc...
(Date:12/17/2008)...nd validation of non-animal alternative test metho... -- MatTek Corporation today announced that the EC...the scientific validity of the Modified EpiDerm Sk... ESAC concluded that the Modified EpiDerm SIT has ...tion of skin irritating and non-irritating test su...
Breaking Medicine Technology:US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4EpiDerm's Skin Irritation Test Fully Validated in European Union 2UNIVAL Inc Becomes a Google Health 28TM 29 Integrated Service 19918 1UNIVAL Inc Becomes a Google Health 28TM 29 Integrated Service 19918 2TV Icon Takes a Shot at Staying Slim 19916 1TV Icon Takes a Shot at Staying Slim 19916 2Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone Study of High Risk Population Finds 2142 1Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone Study of High Risk Population Finds 2142 2Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone Study of High Risk Population Finds 2142 3Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone Study of High Risk Population Finds 2142 4Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone Study of High Risk Population Finds 2142 5Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen Medicine on Stroke Victims 19914 1Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen Medicine on Stroke Victims 19914 2
...ry and secondary endpoints of,study; no negative d...tabine and ribavirin ~, CAMBRIDGE, Mass., June 12,...cals, Inc. today announced results from a phase II...rapy, consisting of,valopicitabine (NM283), Idenix...tis C, pegylated interferon and ribavirin,compared...
...RNewswire/ -- Accera, Inc.,today is presenting dat...inical trial of AC-1202 (Ketasyn) in Alzheimer,s d...national Conference on,Prevention of Dementia in W...rlier clinical and preclinical studies, AC-1202 wa...e memory and,cognition of subjects of a particular...
Other Medicine Technology:Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 2Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 3Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 4
REMstar Plus with C-Flex combines optional integrated humidification, lighted controls, and the comfort of C-Flex.With the addition of C-Flex, the REMstar Plus with C-Flex offers a more comfortable w
...remium CPAP device in ResMeds new S8 series of com...rs are the smallest on the market and are the firs...tegrated heated humidification systems that lock o...emium S8 models also include the option of the new...
The GoodKnight 420 CPAP System is the smallest and lightest continuous positive airway pressure (CPAP) device on the market. It is designed to help active sleep disorder patients preserve their lifes
The clarity and performance of glass with shatterproof safety of plastic.
Medicine Products: